Skip to main content
Top
Published in: World Journal of Surgery 11/2018

01-11-2018 | Original Scientific Report

The Prognostic Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Resected Patients with Pancreatic Adenocarcinoma

Authors: Le-ping Fang, Xiao-yan Xu, Yu Ji, Pu-wen Huang

Published in: World Journal of Surgery | Issue 11/2018

Login to get access

Abstract

Purpose

This research aims to analyze neutrophil-to-lymphocyte ratio (NLR) for resectable pancreatic ductal adenocarcinoma (PDAC) patients and reveal its predictive value.

Methods

We enrolled 389 pancreatic adenocarcinoma patients who had undergone curative surgery between January 1, 2008 and August 15, 2015 in Jiangsu Provincial People’s Hospital, and they were followed up until December 20, 2016. Among them, 219 patients had definite recurrence record in our hospital. The appropriate cutoff value for the NLR was obtained from X-tile software. The association between qualitative variables and NLR was analyzed by Chi-square test or Fisher’s exact test, and for quantitative values, the association was analyzed by independent Student’s t test. Additionally, survival analysis was performed by Kaplan–Meier plots. Independent prognostic factors were found according to Cox regression analysis.

Results

Based on univariate analysis, the elevated preoperative NLR had an important influence on the decreased recurrence-free survival (RFS) (8.2 vs. 14.9 months) and overall survival (OS) (13.7 vs. 22 months), and this result also counted in the multivariate analysis. Regarding OS, both patients with or without postoperative chemotherapy can obtain benefits from low NLR according to subgroup analysis. Stage I and II pancreatic adenocarcinoma patients can get longer OS and RFS from low NLR, while patients with stage III cancer cannot. Regarding recurrence site, high NLR level was also related to distant metastasis (P = 0.02).

Conclusion

Preoperative NLR level could be a useful prognostic indication for resectable pancreatic adenocarcinoma patients.
Literature
1.
go back to reference Khorana AA, Mangu PB, Berlin J et al (2016) Potentially curable pancreatic cancer: American society of clinical oncology clinical practice guideline. J Clin Oncol 34(21):2541–2556CrossRef Khorana AA, Mangu PB, Berlin J et al (2016) Potentially curable pancreatic cancer: American society of clinical oncology clinical practice guideline. J Clin Oncol 34(21):2541–2556CrossRef
2.
go back to reference Li GJ, Xu HW, Ji JJ et al (2016) Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma. Onco Targets Ther 9:1085–1092PubMedPubMedCentral Li GJ, Xu HW, Ji JJ et al (2016) Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma. Onco Targets Ther 9:1085–1092PubMedPubMedCentral
3.
go back to reference Singh G, Nassri A, Kim D et al (2017) Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma. World J Gastrointest Pharmacol Ther 8(1):60–66CrossRef Singh G, Nassri A, Kim D et al (2017) Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma. World J Gastrointest Pharmacol Ther 8(1):60–66CrossRef
4.
go back to reference Mayo SC, Nathan H, Cameron JL et al (2012) Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. Cancer 118(10):2674–2681CrossRef Mayo SC, Nathan H, Cameron JL et al (2012) Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. Cancer 118(10):2674–2681CrossRef
5.
go back to reference Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet (London, England) 357(9255):539–545CrossRef Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet (London, England) 357(9255):539–545CrossRef
6.
go back to reference Mantovani A, Allavena P, Sica A et al (2008) Cancer-related inflammation. Nature 454(7203):436–444CrossRef Mantovani A, Allavena P, Sica A et al (2008) Cancer-related inflammation. Nature 454(7203):436–444CrossRef
7.
go back to reference Kim JH, Lee JY, Kim HK et al (2017) Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer. World J Gastroenterol 23(3):505–515CrossRef Kim JH, Lee JY, Kim HK et al (2017) Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer. World J Gastroenterol 23(3):505–515CrossRef
8.
go back to reference Altan M Haberal HB Akdogan B et al (2017) A critical prognostic analysis of neutrophillymphocyte ratio for patients undergoing nephroureterectomy due to upper urinary tract urothelial carcinoma. Int J Clin Oncol 22(5): 964–971CrossRef Altan M Haberal HB Akdogan B et al (2017) A critical prognostic analysis of neutrophillymphocyte ratio for patients undergoing nephroureterectomy due to upper urinary tract urothelial carcinoma. Int J Clin Oncol 22(5): 964–971CrossRef
9.
go back to reference Ben Q, An W, Wang L et al (2015) Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma. Pancreas 44(3):471–477PubMed Ben Q, An W, Wang L et al (2015) Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma. Pancreas 44(3):471–477PubMed
10.
go back to reference Gemenetzis G, Bagante F, Griffin JF et al. (2017) Neutrophil-to-lymphocyte ratio is a predictive marker for invasive malignancy in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 266(2): 339–345CrossRef Gemenetzis G, Bagante F, Griffin JF et al. (2017) Neutrophil-to-lymphocyte ratio is a predictive marker for invasive malignancy in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 266(2): 339–345CrossRef
11.
go back to reference Hu D, Zhang H, Lin X et al (2017) Elevated preoperative neutrophil-to-lymphocyte ratio can predict poor survival in early stage gastric cancer patients receiving radical gastrectomy: the Fujian prospective investigation of cancer (FIESTA) study. J Cancer 8(7):1214–1222CrossRef Hu D, Zhang H, Lin X et al (2017) Elevated preoperative neutrophil-to-lymphocyte ratio can predict poor survival in early stage gastric cancer patients receiving radical gastrectomy: the Fujian prospective investigation of cancer (FIESTA) study. J Cancer 8(7):1214–1222CrossRef
12.
go back to reference Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21):7252–7259CrossRef Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21):7252–7259CrossRef
13.
go back to reference Ling Q, Xu X, Ye P et al (2017) The prognostic relevance of primary tumor location in patients undergoing resection for pancreatic ductal adenocarcinoma. Oncotarget 8(9):15159–15167CrossRef Ling Q, Xu X, Ye P et al (2017) The prognostic relevance of primary tumor location in patients undergoing resection for pancreatic ductal adenocarcinoma. Oncotarget 8(9):15159–15167CrossRef
14.
go back to reference Fukuda S, Oussoultzoglou E, Bachellier P et al (2007) Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma. Arch Surg (Chicago, Ill: 1960) 142(2):172–179 (discussion 180) CrossRef Fukuda S, Oussoultzoglou E, Bachellier P et al (2007) Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma. Arch Surg (Chicago, Ill: 1960) 142(2):172–179 (discussion 180) CrossRef
15.
go back to reference Liu L, Katz MH, Lee SM et al (2015) Superior mesenteric artery margin of posttherapy pancreaticoduodenectomy and prognosis in patients with pancreatic ductal adenocarcinoma. Am J Surg Pathol 39(10):1395–1403CrossRef Liu L, Katz MH, Lee SM et al (2015) Superior mesenteric artery margin of posttherapy pancreaticoduodenectomy and prognosis in patients with pancreatic ductal adenocarcinoma. Am J Surg Pathol 39(10):1395–1403CrossRef
16.
go back to reference Houghton AM, Rzymkiewicz DM, Ji H et al (2010) Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med 16(2):219–223CrossRef Houghton AM, Rzymkiewicz DM, Ji H et al (2010) Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med 16(2):219–223CrossRef
17.
go back to reference McDonald B, Spicer J, Giannais B et al (2009) Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms. Int J Cancer 125(6):1298–1305CrossRef McDonald B, Spicer J, Giannais B et al (2009) Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms. Int J Cancer 125(6):1298–1305CrossRef
18.
go back to reference Muller I, Munder M, Kropf P et al (2009) Polymorphonuclear neutrophils and T lymphocytes: Strange bedfellows or brothers in arms? Trends Immunol 30(11):522–530CrossRef Muller I, Munder M, Kropf P et al (2009) Polymorphonuclear neutrophils and T lymphocytes: Strange bedfellows or brothers in arms? Trends Immunol 30(11):522–530CrossRef
19.
go back to reference Pillay J, Kamp VM, van Hoffen E et al (2012) A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Investig 122(1):327–336CrossRef Pillay J, Kamp VM, van Hoffen E et al (2012) A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Investig 122(1):327–336CrossRef
20.
go back to reference Wang TT, Zhao YL, Peng LS et al (2017) Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway. Gut 66:1900–1911CrossRef Wang TT, Zhao YL, Peng LS et al (2017) Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway. Gut 66:1900–1911CrossRef
21.
go back to reference Inman KS, Francis AA, Murray NR (2014) Complex role for the immune system in initiation and progression of pancreatic cancer. World J Gastroenterol 20(32):11160–11181CrossRef Inman KS, Francis AA, Murray NR (2014) Complex role for the immune system in initiation and progression of pancreatic cancer. World J Gastroenterol 20(32):11160–11181CrossRef
22.
go back to reference Zhang JW, Huang L, Xu AM (2017) Preoperative monocyte-lymphocyte and neutrophil-lymphocyte but not platelet-lymphocyte ratios are predictive of clinical outcomes in resected patients with non-metastatic Siewert type II/III adenocarcinoma of esophagogastric junction: a prospective cohort study (the AMONP corhort). Oncotarget 8(34):57516–57527PubMedPubMedCentral Zhang JW, Huang L, Xu AM (2017) Preoperative monocyte-lymphocyte and neutrophil-lymphocyte but not platelet-lymphocyte ratios are predictive of clinical outcomes in resected patients with non-metastatic Siewert type II/III adenocarcinoma of esophagogastric junction: a prospective cohort study (the AMONP corhort). Oncotarget 8(34):57516–57527PubMedPubMedCentral
23.
go back to reference Hsueh C, Tao L, Zhang M et al (2017) The prognostic value of preoperative neutrophils, platelets, lymphocytes, monocytes and calculated ratios in patients with laryngeal squamous cell cancer. Oncotarget 8(36):60514–60527CrossRef Hsueh C, Tao L, Zhang M et al (2017) The prognostic value of preoperative neutrophils, platelets, lymphocytes, monocytes and calculated ratios in patients with laryngeal squamous cell cancer. Oncotarget 8(36):60514–60527CrossRef
24.
go back to reference Zhang J, Huang SH, Li H et al (2013) Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer. Med Oncol (Northwood, London, England) 30(1):352CrossRef Zhang J, Huang SH, Li H et al (2013) Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer. Med Oncol (Northwood, London, England) 30(1):352CrossRef
25.
go back to reference Xiao Y, Xie Z, Shao Z et al (2016) Neutrophil and lymphocyte counts at diagnosis are associated with overall survival of pancreatic cancer: a retrospective cohort study. Medicine (Baltimore) 95(40):e5024CrossRef Xiao Y, Xie Z, Shao Z et al (2016) Neutrophil and lymphocyte counts at diagnosis are associated with overall survival of pancreatic cancer: a retrospective cohort study. Medicine (Baltimore) 95(40):e5024CrossRef
26.
go back to reference Clark EJ, Connor S, Taylor MA et al (2007) Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma. HPB (Oxford) 9(6):456–460CrossRef Clark EJ, Connor S, Taylor MA et al (2007) Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma. HPB (Oxford) 9(6):456–460CrossRef
27.
go back to reference Schueneman AJ, Sugar EA, Uram J et al (2013) Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine. Ann Surg Oncol 20(Suppl 3):S725–S730CrossRef Schueneman AJ, Sugar EA, Uram J et al (2013) Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine. Ann Surg Oncol 20(Suppl 3):S725–S730CrossRef
28.
go back to reference Stotz M, Gerger A, Eisner F et al (2013) Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 109(2):416–421CrossRef Stotz M, Gerger A, Eisner F et al (2013) Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 109(2):416–421CrossRef
29.
go back to reference Cheng H, Luo G, Lu Y et al (2016) The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients. Pancreatology 16(6):1080–1084CrossRef Cheng H, Luo G, Lu Y et al (2016) The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients. Pancreatology 16(6):1080–1084CrossRef
30.
go back to reference Garcea G, Ladwa N, Neal CP et al (2011) Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma. World J Surg 35(4):868–872CrossRef Garcea G, Ladwa N, Neal CP et al (2011) Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma. World J Surg 35(4):868–872CrossRef
31.
go back to reference Yang JJ, Hu ZG, Shi WX et al (2015) Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis. World J Gastroenterol 21(9):2807–2815CrossRef Yang JJ, Hu ZG, Shi WX et al (2015) Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis. World J Gastroenterol 21(9):2807–2815CrossRef
32.
go back to reference Licata LA, Nguyen CT, Burga RA et al (2013) Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils. J Leukoc Biol 94(4):813–823CrossRef Licata LA, Nguyen CT, Burga RA et al (2013) Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils. J Leukoc Biol 94(4):813–823CrossRef
33.
go back to reference Pavlidis ET, Pavlidis TE (2018) Pathophysiological consequences of obstructive jaundice and perioperative management. Hepatobiliary Pancreat Dis Int 17(1):17–21CrossRef Pavlidis ET, Pavlidis TE (2018) Pathophysiological consequences of obstructive jaundice and perioperative management. Hepatobiliary Pancreat Dis Int 17(1):17–21CrossRef
34.
go back to reference Goh BK, Tan DM, Chan CY et al (2015) Are preoperative blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios useful in predicting malignancy in surgically-treated mucin-producing pancreatic cystic neoplasms? J Surg Oncol 112(4):366–371CrossRef Goh BK, Tan DM, Chan CY et al (2015) Are preoperative blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios useful in predicting malignancy in surgically-treated mucin-producing pancreatic cystic neoplasms? J Surg Oncol 112(4):366–371CrossRef
Metadata
Title
The Prognostic Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Resected Patients with Pancreatic Adenocarcinoma
Authors
Le-ping Fang
Xiao-yan Xu
Yu Ji
Pu-wen Huang
Publication date
01-11-2018
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 11/2018
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-018-4686-7

Other articles of this Issue 11/2018

World Journal of Surgery 11/2018 Go to the issue